Literature DB >> 31739881

Topical Tranexamic Acid Is Effective in Cementless Total Knee Arthroplasty.

Stephen Chambers1, Luke Tidwell1, Anita Kerkhof1, Richard Smith1, William M Mihalko2.   

Abstract

Surgical techniques used to decrease the amount of blood lost during the procedure range from tourniquets to electrocautery and, more recently, the use of antifibrinolytics. Currently, tranexamic acid is the most commonly used antifibrinolytic in arthroplasty procedures. It was previously thought that intravenous tranexamic acid was more effective than topical tranexamic acid, but had an increased risk of thrombosis and cardiac events; however, this study showed that topical tranexamic acid is as effective in decreasing blood loss and the need for a blood transfusion after hybrid fixation total knee arthroplasty as with cemented total knee arthroplasty.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood loss; Hybrid implant fixation; Topical tranexamic acid; Total knee arthroplasty; Transfusion

Mesh:

Substances:

Year:  2019        PMID: 31739881     DOI: 10.1016/j.ocl.2019.08.002

Source DB:  PubMed          Journal:  Orthop Clin North Am        ISSN: 0030-5898            Impact factor:   2.472


  3 in total

1.  A matched cohort study between cementless TKA and cemented TKA shows a reduction in tourniquet time and manipulation rate.

Authors:  J A Dubin; G H Westrich
Journal:  J Orthop       Date:  2020-09-18

2.  [Comparison of hemostatic effect and safety in primary unilateral total hip arthroplasty receiving different anticoagulants after anti-fibrinolysis with tranexamic acid].

Authors:  Zengfa Deng; Puyi Sheng; Dongliang Xu; Ming Fu; Aishan He; Weiming Liao; Yan Kang
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-12-15

3.  Tranexamic acid reduces blood cost in long-segment spinal fusion surgery: A randomized controlled study protocol.

Authors:  Linyu Yang; Xufeng Jia; Jian Yang; Jianping Kang
Journal:  Medicine (Baltimore)       Date:  2020-09-11       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.